Hangzhou Biotest Biotech Co.,Ltd. (688767.SS) SHH

Currency In CNY

AD

Valuation

Market Cap5.52B
Enterprise Value4.05B
P/E Ratio193.11
PEG Ratio-2.65
Price/Sales Ratio12.37
Price/Book Ratio2.61
Enterprise/Revenue9.87
Enterprise/EBITDA85.03

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.04
Operating Margin0.05
AD

Management Effectiveness

Return On Assets0.01
Return On Equity0.01

Income Statement

Revenue448.37M
Revenue/Share3.14
Gross Profit448.37M
EBITDA35.47M
Net Income46.8M
Diluted EPS0.32

Balance Sheet

Total Cash1.26B
Total Cash/Share8.64
Total Debt100.18M
Total Debt/Equity0.05
Current Ratio9.51
Book Value Per Share14.65

Price History

52-Week Change-11.83
52-Week High50.98
52-Week Low30.4
Moving Average 50 Days39.34
Moving Average 200 Days37.53

Statistics

Average Volume2.57M
Shares Outstanding149.33M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.7
Trailing Annual Dividend Yield1.84
Payout Ratio5.99
Last Split FactorN/A
Last Split DateN/A
AD